Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam + propofol for emergence agitation in elderly general anesthesia
ChiCTR2500107259Phase 4Not yet recruiting
- Sponsor
- The Second People's Hospital of Kashgar Prefecture
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Emergence agitation (EA) (2 arms), sponsored by The Second People's Hospital of Kashgar Prefecture. Primary endpoint: Awakening restlessness. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2500107259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107259.